Open access
Open access
Powered by Google Translator Translator

Genetics

Large genomic analysis has identified 13 new genomic regions associated with susceptibility and severity to Covid-19.

13 Jul, 2021 | 09:59h | UTC

Mapping the human genetic architecture of COVID-19 – Nature

Commentaries: The quest to find genes that drive severe COVID – Nature AND Gene hunters turn up new clues to help explain why Covid-19 hits some people so hard – STAT AND Large genomic analysis highlights COVID-19 risk factors – Broad Institute of MIT and Harvard AND A new study finds genetic variations in Covid patients that could point to better drug treatments. – The New York Times AND How your DNA may affect whether you get COVID-19 or become gravely ill – ScienceNews

 


WHO issues new recommendations on human genome editing for the advancement of public health.

13 Jul, 2021 | 09:42h | UTC

WHO issues new recommendations on human genome editing for the advancement of public health – World Health Organization

See reports:

Human genome editing: recommendations

Human genome editing: a framework for governance

Commentaries: New Global Recommendations for Human Genome Editing may Improve Use to Cure and Treat Diseases – Health Policy Watch AND WHO should lead on genome-editing policy, advisers say – Nature AND WHO Calls for Global Registry of Human Genome Editing – HealthDay AND Expert reaction to the WHO’s newly published recommendations and governance framework for human genome editing – Science Media Centre

 

Commentary on Twitter (thread – click for more)

 


Review: Advances in the diagnosis and treatment of primary ciliary dyskinesia.

21 Jun, 2021 | 08:27h | UTC

Advances in the Diagnosis and Treatment of Primary Ciliary Dyskinesia: A Review – JAMA Otolaryngology – Head & Neck Surgery (free for a limited period)

 


CDC now calls coronavirus Delta variant a ‘variant of concern’.

17 Jun, 2021 | 09:53h | UTC

CDC now calls coronavirus Delta variant a ‘variant of concern’ – CNN

Guidance: SARS-CoV-2 Variant Classifications and Definitions – Centers for Disease Control and Prevention

 

Commentary on Twitter

 


[Preprint] Covid-19 B.1.617.2 variant of concern (Delta) is associated with increased transmissibility compared to B.1.1.7 (Alpha) that will rapidly lead to B.1.617.2 becoming the prevailing variant in the UK.

4 Jun, 2021 | 10:36h | UTC

Interim estimates of increased transmissibility, growth rate, and reproduction number of the Covid-19 B.1.617.2 variant of concern in the United Kingdom – medRxiv

Related: Covid: Indian variant ‘now dominant’ in the UK – BBC

 


After COVID-19 successes, researchers push to develop mRNA vaccines for other infectious diseases and cancer.

2 Jun, 2021 | 08:34h | UTC

After COVID-19 successes, researchers push to develop mRNA vaccines for other diseases – Nature Medicine

 


What scientists know about new, fast-spreading coronavirus variants.

26 May, 2021 | 08:45h | UTC

What scientists know about new, fast-spreading coronavirus variants – Nature

 


A ‘more rapidly spreading virus’ (B.1.617 variant) is fueling India’s mega COVID-19 surge, WHO chief scientist says

11 May, 2021 | 09:16h | UTC

A ‘more rapidly spreading virus’ is fueling India’s mega COVID-19 surge, WHO chief scientist says – Insider

See also: WHO Upgrades Virus Mutation Driving India’s COVID Surge To ‘Variant of Concern’ – Global Cases Start To ‘Plateau’ – Health Policy Watch AND Why India needs oxygen more urgently than vaccines – Vox AND WHO names B1617 fourth COVID-19 variant of concern – CIDRAP

 


Case-control study shows an increased risk of colorectal cancer in first degree relatives of patients with colorectal polyps.

10 May, 2021 | 00:50h | UTC

Risk of colorectal cancer in first degree relatives of patients with colorectal polyps: nationwide case-control study in Sweden – The BMJ

Commentaries: Intestinal polyps in close relatives can increase risk of colorectal cancer – Karolinska Institutet AND Relatives’ Colonoscopy Results Could Affect Your Colon Cancer Risk – HealthDay

 

Commentary on Twitter

 


Study on five million Swedes finds links between blood groups and disease risks

3 May, 2021 | 05:09h | UTC

News Release: Study on five million Swedes finds links between blood groups and disease risks – Karolinska Institutet

Original Study: An agnostic study of associations between ABO and RhD blood group and phenome-wide disease risk – eLife

 


One million coronavirus sequences: popular genome site hits mega milestone

25 Apr, 2021 | 21:59h | UTC

One million coronavirus sequences: popular genome site hits mega milestone – Nature

 


How mRNA Technology Could Change the World

5 Apr, 2021 | 01:36h | UTC

How mRNA Technology Could Change the World – The Atlantic (a few articles per month are free)

 


RCT: Lumasiran, an RNAi Therapeutic for Primary Hyperoxaluria Type 1

5 Apr, 2021 | 01:01h | UTC

Lumasiran, an RNAi Therapeutic for Primary Hyperoxaluria Type 1 – New England Journal of Medicine (link to abstract – $ for full-text)

 


Another study indicates SARS-CoV-2 variant B.1.351, but not variant B.1.1.7, has partial resistance to neutralizing antibodies generated by natural infection or mRNA vaccination

28 Mar, 2021 | 22:53h | UTC

Sensitivity of infectious SARS-CoV-2 B.1.1.7 and B.1.351 variants to neutralizing antibodies – Nature Medicine

 

Commentaries on Twitter

 


Opinion | The Coronavirus Variants Don’t Seem to Be Highly Variable So Far

28 Mar, 2021 | 22:46h | UTC

The Coronavirus Variants Don’t Seem to Be Highly Variable So Far – Scientific American

 


70-gene signature as an aid for treatment decisions in early breast cancer: updated results of the phase 3 randomised MINDACT trial with an exploratory analysis by age

14 Mar, 2021 | 20:07h | UTC

70-gene signature as an aid for treatment decisions in early breast cancer: updated results of the phase 3 randomised MINDACT trial with an exploratory analysis by age – The Lancet Oncology (link to abstract – $ for full-text)

 


Position Statement: The Role of Pharmacogenomics in Contemporary Cardiovascular Therapy

11 Mar, 2021 | 07:53h | UTC

The Role of Pharmacogenomics in Contemporary Cardiovascular Therapy: A position statement from the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy – European Heart Journal – Cardiovascular Pharmacotherapy

 


Clinical practice guidelines for BRCA1 and BRCA2 genetic testing

21 Feb, 2021 | 21:43h | UTC

Clinical practice guidelines for BRCA1 and BRCA2 genetic testing – European Journal of Cancer

 

Commentary on Twitter

 


BRUGADA-RISK: A primary prevention clinical risk score model for patients with Brugada Syndrome

18 Feb, 2021 | 02:57h | UTC

A Primary Prevention Clinical Risk Score Model for Patients With Brugada Syndrome (BRUGADA-RISK) – JACC: Clinical Electrophysiology

Commentary: Risk Score Model for Brugada Syndrome – American College of Cardiology

 


Breast Cancer Risk Genes — Association Analysis in More than 113,000 Women

10 Feb, 2021 | 01:07h | UTC

Breast Cancer Risk Genes — Association Analysis in More than 113,000 Women – New England Journal of Medicine

Commentary: Protein-Truncating and Rare Missense Variants in Breast Cancer Risk Genes: Association With Disease Risk – The ASCO Post

 


A population-based study of genes previously implicated in breast cancer

10 Feb, 2021 | 01:05h | UTC

A Population-Based Study of Genes Previously Implicated in Breast Cancer – New England Journal of Medicine (link to abstract – $ for full-text)

 


Consensus recommendations: Diagnosis and management of Bartter syndrome

3 Feb, 2021 | 01:04h | UTC

Diagnosis and management of Bartter syndrome: executive summary of the consensus and recommendations from the European Rare Kidney Disease Reference Network Working Group for Tubular Disorders – Kidney International

 


How Covid-19 mutations are changing the pandemic

29 Jan, 2021 | 01:55h | UTC

How Covid-19 mutations are changing the pandemic – BBC

 


NCCN Guideline: Genetic/familial high-risk assessment: breast, ovarian, and pancreatic

14 Jan, 2021 | 01:28h | UTC

Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology – Journal of the National Comprehensive Cancer Network

 


New SARS-CoV-2 variants: increased transmissibility likely to cause more deaths and possibly a new wave of the disease

10 Jan, 2021 | 20:54h | UTC

 


Stay Updated in Your Specialty

No spam, just news.